<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: dana farber</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'dana farber'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22dana+farber%22&t=%22dana+farber%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:10:12 +0100</lastBuildDate>
        <item>
            <title>Realistic Medicine: The Kind Of Thinking To Look For</title>
            <link>http://www.medworm.com/index.php?rid=4382762&amp;cid=t_117681_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Frealistic-medicine-the-kind-of-thinking-to-look-for%2F2011.01.21</link>
            <description>There are several stages in becoming an empowered, engaged, activated patient &amp;#8212; a capable, responsible partner in getting good care for yourself, your family, whoever you’re caring for. One ingredient is to know what to expect, so you can tell when things seem right and when they don’t.
Researching a project today, I came across an article* published in 2006: &amp;#8221;Key Learning from the Dana-Farber Cancer Institute’s 10-Year Patient Safety Journey.&amp;#8221; This table shows the attitude you’ll find in an organization that has realized the challenges of medicine and is dealing with them realistically:

“Errors are everywhere.” “Great care in a high-risk environment.” What kind of attitude is that? It’s accurate.
This work began after the death of Boston Globe healt...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4382762</comments>
            <pubDate>Fri, 21 Jan 2011 22:00:29 +0100</pubDate>
            <guid isPermaLink="false">4382762</guid>        </item>
        <item>
            <title>Caris Life Sciences Launches Molecular Profiling Service For Ovarian Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=4349659&amp;cid=t_117681_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2011%2F01%2F14%2Fcaris-life-sciences-launches-molecular-profiling-service-for-ovarian-cancer-patients%2F</link>
            <description>Caris Life Sciences announces the launch of a new molecular profiling service for ovarian cancer patients Caris Life Sciences, Inc. (Caris), a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, announced the launch of a new, Caris Target Now™ molecular profile [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4349659</comments>
            <pubDate>Fri, 14 Jan 2011 22:11:53 +0100</pubDate>
            <guid isPermaLink="false">4349659</guid>        </item>
        <item>
            <title>Girls with Stage I Ovarian Germ-Cell Tumors Can Safely Skip Chemotherapy Until Recurrence</title>
            <link>http://www.medworm.com/index.php?rid=4122024&amp;cid=t_117681_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F10%2F31%2Fgirls-with-stage-i-ovarian-germ-cell-tumors-can-safely-skip-chemotherapy-until-recurrence%2F</link>
            <description>Researchers from Dana-Farber/Children&amp;#8217;s Hospital Cancer Center found that as many as 50 percent of young girls treated for germ-cell ovarian tumors may be safely spared chemotherapy using a &amp;#8220;watch and wait&amp;#8221; strategy to determine whether follow-up treatment is needed. Researchers from Dana-Farber/Children&amp;#8217;s Hospital Cancer Center (DF/CHCC) found that as many as 50 percent of young girls [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4122024</comments>
            <pubDate>Sun, 31 Oct 2010 22:23:31 +0100</pubDate>
            <guid isPermaLink="false">4122024</guid>        </item>
        <item>
            <title>Novartis, Dana-Farber, An Angry Exec And Money</title>
            <link>http://www.medworm.com/index.php?rid=4119713&amp;cid=t_117681_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fiqx9Ideosb4%2F</link>
            <description>There&amp;#8217;s nothing like a nasty battle over the rights to a drug under development to make for interesting reading. And so we present you with some intense legal haggling over a molecule known as WZ4002, which was discovered by researchers at the Dana-Farber Cancer Institute in Boston for combating non small-cell lung cancer with specific gene mutations. The compound is potentially quite valuable because it may be able to treat patients who don&amp;#8217;t respond to existing cancer pills.
The dispute, however, is not your run-of-the-mill spat over development rights. Instead, the lawsuit peels back the curtain on some of the jockeying that occurs among universities, drugmakers and scientists when potentially lucrative intellectual property rights are in play. Here&amp;#8217;s why: the legal ba...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4119713</comments>
            <pubDate>Fri, 29 Oct 2010 14:35:42 +0100</pubDate>
            <guid isPermaLink="false">4119713</guid>        </item>
        <item>
            <title>Pharmalot… Pharmalittle… The Weekend Nears</title>
            <link>http://www.medworm.com/index.php?rid=3999295&amp;cid=t_117681_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FTCrv077MheI%2F</link>
            <description>And so the end of another work week is near. Which means the time has come to plan your weekend activities. Anything special in the offing? How about picking apples? Or a walk in the park? We plan to watch one of the short people on the football field and catch up on some reading. Meanwhile, another day awaits. So here are a few items to help you along. And whatever you do this weekend, have a great time&amp;#8230;
Amgen And J&amp;#038;J Recall Some Anemia Meds (Reuters)
EMA Rejects Merck KGaA&amp;#8217;s MS Pill (Bloomberg News)
Alnylam To Cut Up To 30 Percent Of Workforce (Associated Press)
Sanofi-Aventis Signs Deal With Dana Farber Cancer Institute (PharmaTimes)
Glaxo&amp;#8217;s Advair Follow-Up Shows Promise In Tests (Reuters)
Xanodyne Pharma Plans Staff Cuts (The Cincinnati Enquirer)
EU Finds No Lin...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3999295</comments>
            <pubDate>Fri, 24 Sep 2010 11:53:50 +0100</pubDate>
            <guid isPermaLink="false">3999295</guid>        </item>
        <item>
            <title>2010-2011 U.S. News &amp; World Report “Best Hospitals” List</title>
            <link>http://www.medworm.com/index.php?rid=3758063&amp;cid=t_117681_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F07%2F15%2F2010-2011-u-s-news-world-report-best-hospitals-list%2F</link>
            <description>This week, U.S. News &amp;#38; World Report issued its 2010-2011 rankings of the best U.S. hospitals for adults. The University of Texas, M.D. Anderson Cancer Center is rated #1 in cancer treatment, and Johns Hopkins is rated #1 in gynecology and #1 overall based upon all medical specialties. If you would like more information regarding [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3758063</comments>
            <pubDate>Thu, 15 Jul 2010 20:16:29 +0100</pubDate>
            <guid isPermaLink="false">3758063</guid>        </item>
        <item>
            <title>2009-2010 U.S. News &amp; World Report Best U.S. Hospital Rankings</title>
            <link>http://www.medworm.com/index.php?rid=2611148&amp;cid=t_117681_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F07%2F16%2F2009-2010-u-s-news-world-report-best-u-s-hospital-rankings%2F</link>
            <description>Today, U.S. News &amp;#38; World Report issued its 2009-2010 rankings of the best U.S. hospitals for adults. The University of Texas, M.D. Anderson Cancer Center is rated #1 in cancer treatment; Brigham and Women&amp;#8217;s Hospital is rated #1 in gynecology; and Johns Hopkins is rated #1 overall based upon all medical specialties.
If you would like [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2611148</comments>
            <pubDate>Fri, 17 Jul 2009 00:14:29 +0100</pubDate>
            <guid isPermaLink="false">2611148</guid>        </item>
        <item>
            <title>Genetic Testing For Hereditary Breast and Ovarian Cancers Greatly Underutilized By High-Risk Women</title>
            <link>http://www.medworm.com/index.php?rid=2442555&amp;cid=t_117681_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F05%2F24%2Fgenetic-testing-for-hereditary-breast-and-ovarian-cancers-greatly-underutilized-by-high-risk-women%2F</link>
            <description>A women&amp;#8217;s lifetime breast cancer risk is approximately 13 percent, and her ovarian cancer risk is less than 2 percent.  But women with BRCA1 (BReast CAncer 1) or BRCA2 (BReast CAncer 2) gene mutations may be 3 to 7 times more likely to develop breast cancer, and 9 to 30 times more likely to develop [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2442555</comments>
            <pubDate>Mon, 25 May 2009 01:03:00 +0100</pubDate>
            <guid isPermaLink="false">2442555</guid>        </item>
        <item>
            <title>Kids with cancer watch ironworkers spraypaint their names</title>
            <link>http://www.medworm.com/index.php?rid=2210543&amp;cid=t_117681_87_f&amp;fid=34935&amp;url=http%3A%2F%2Fmedicine.com.my%2Fwp%2F%3Fp%3D6193</link>
            <description>It has become a beloved ritual at Dana-Farber: Every day, children who come to the clinic write their names on sheets of paper and tape them to the windows of the walkway for ironworkers to see. And, every day, the ironworkers paint the names onto I-beams and hoist them into place as they add floors to the new 14-story Yawkey Center for Cancer Careread more | digg story (Source: Malaysian Medical Resources)</description>
            <author>Malaysian Medical Resources</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2210543</comments>
            <pubDate>Mon, 23 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2210543</guid>        </item>
        <item>
            <title>Patty Franchi Flaherty Loses Battle to Ovarian Cancer, But Deserves a Long Standing Ovation</title>
            <link>http://www.medworm.com/index.php?rid=1727797&amp;cid=t_117681_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F08%2F19%2Fpatty-franchi-flaherty-loses-battle-to-ovarian-cancer-but-deserves-a-long-standing-ovation%2F</link>
            <description>It is with deep regret that I must inform you that, Patty Franchi Flaherty, founder of the nonprofit organization Ovations for the Cure of Ovarian Cancer, peacefully succumbed to her nine-year battle with the disease on August 18, 2008, surrounded by friends and family. She was 53 years old. Patty was a legendary ovarian cancer [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727797</comments>
            <pubDate>Tue, 19 Aug 2008 19:34:58 +0100</pubDate>
            <guid isPermaLink="false">1727797</guid>        </item>
        <item>
            <title>The Emerging Field of Oncofertility</title>
            <link>http://www.medworm.com/index.php?rid=1727803&amp;cid=t_117681_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F07%2F29%2Fthe-emerging-field-of-oncofertility%2F</link>
            <description>&amp;#8220;Welcome to the burgeoning world of oncofertility. As cancer survival rates climb and patients focus on quality-of-life issues, especially fertility, Dauer and others like her are forcing two very different medical specialties-oncology and assisted reproduction-to come together. ‘The narrative of cancer is no longer that it&amp;#8217;s a death sentence; it&amp;#8217;s a bump in your [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1727803</comments>
            <pubDate>Tue, 29 Jul 2008 18:35:49 +0100</pubDate>
            <guid isPermaLink="false">1727803</guid>        </item>
        <item>
            <title>Senator Kennedy's Cancer Family History</title>
            <link>http://www.medworm.com/index.php?rid=1470033&amp;cid=t_117681_131_f&amp;fid=35743&amp;url=http%3A%2F%2Fthegenesherpa.blogspot.com%2F2008%2F05%2Fsenator-kennedys-cancer-family-history.html</link>
            <description>Dr Lubin, my partner at Helix Health asked me this question.&quot;Am I the only one to think about this? Ted Kennedy Junior had Osteosarcoma. His other son Patrick had a Spinal Tumor (I'd love to see the path on that). Ted Senior has a Glioma.....Likely GBM. In addition, his daughter had lung cancer at 43 (Was she a smoker?) and breast. So what this tells me is that the Kennedy family may have Li-Fraumeni.&quot;Well, perhaps we should call Dana Farber. Why? Because, Dr Rosenthal over there does not seem to be impressed. from the Globe:Dr. David S. Rosenthal, former president of the American Cancer Society and the medical director of the Leonard P. Zakim Center for Integrated Therapies at the Dana-Farber Cancer Institute, said that while he is not familiar with the details of the Kennedys' medical hi...</description>
            <author>Gene Sherpas: Personalized Medicine and You</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1470033</comments>
            <pubDate>Tue, 27 May 2008 15:55:00 +0100</pubDate>
            <guid isPermaLink="false">1470033</guid>        </item>
        <item>
            <title>Pediatric Brain Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1310997&amp;cid=t_117681_122_f&amp;fid=34755&amp;url=http%3A%2F%2Fneuropsychological.blogspot.com%2F2008%2F03%2Fpediatric-brain-tumors.html</link>
            <description>From today's New York Times:A Daring Treatment, a Little Girl’s SurvivalBy DENISE GRADYPublished: March 18, 2008Melanie Joy McDaniel is a study subject but also a reminder of how medical research can change lives.[ ... Read the full article ... ] (Source: BrainBlog)</description>
            <author>BrainBlog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1310997</comments>
            <pubDate>Tue, 18 Mar 2008 15:46:00 +0100</pubDate>
            <guid isPermaLink="false">1310997</guid>        </item>
        <item>
            <title>NFL football player Joe Andruzzi treated for lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=658837&amp;cid=t_117681_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F05%2Fnfl-football-player-joe-andruzzi-treated-for-lymphoma%2F</link>
            <description>Filed under: Chemotherapy, Non-Hodgkins Lymphoma, Daily news, SportsFormer Green Bay, New England, and Cleveland football player Joe Andruzzi has just completed the first of a 12-step series of chemotherapy treatments for Burkitt's lymphoma, a form of non-Hodgkins lymphoma.
Andruzzi, married and dad to four children, was released by the Browns on May 2 so he and his family could move to New Jersey. Then last week, Andruzzi began experiencing abdominal pain and other symptoms. He consulted with the Browns' medical staff, underwent a colonoscopy, learned an abnormality was found, and then headed to Dana-Farber Cancer Institute in Boston where he was diagnosed with Burkitt's.
The cure rate for Burkitt's -- a rapidly growing, rare form of cancer that strikes only 100 people in the United State...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=658837</comments>
            <pubDate>Tue, 05 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">658837</guid>        </item>
        <item>
            <title>Avandia Goes Platinum</title>
            <link>http://www.medworm.com/index.php?rid=601911&amp;cid=t_117681_87_f&amp;fid=34867&amp;url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F05%2F10%2Favandia-goes-platinum%2F</link>
            <description>Filed under: Type 2, Drugs, ResearchSituated almost right next to each other in Boston, helping the lives of so many who need it, are the Joslin Diabetes Center and the Dana-Farber Cancer Institute. Patients from around the globe visit this particular area of Beantown, receiving some of the best treatment available for their respective illness. Now, scientists have found that there is much more of a connection between diabetes and cancer than the zip code of these research centers.
Plans are already being drawn up for initial human trials for the use of a diabetes drug that has been shown to dramatically increase the effectiveness of platinum-based chemotherapy. Researchers from Dana-Farber found that when the diabetes drug Rosizitaglone (more popularly known by its brand name of Avandia) ...</description>
            <author>The Diabetes Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=601911</comments>
            <pubDate>Thu, 10 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">601911</guid>        </item>
        <item>
            <title>Isunlin sensitivity drug could be used in conjunction with chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=601868&amp;cid=t_117681_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F10%2Fisunlin-sensitivity-drug-could-be-used-in-conjunction-with-chemo%2F</link>
            <description>Filed under: Drug, Ovarian Cancer, Chemotherapy, Lung Cancer, ResearchSituated almost right next to each other in Boston, helping the lives of so many who need it, are the Joslin Diabetes Center and the Dana-Farber Cancer Institute. Patients from around the globe visit this particular area of Beantown, receiving some of the best treatment available for their respective illness. Now, scientists have found that there is much more of a connection between diabetes and cancer than the zip code of these research centers.
Plans are already being drawn up for initial human trials for the use of a diabetes drug that has been shown to dramatically increase the effectiveness of platinum-based chemotherapy. Researchers from Dana-Farber found that when the diabetes drug Rosizitaglone (more popularly kn...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=601868</comments>
            <pubDate>Thu, 10 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">601868</guid>        </item>
    </channel>
</rss>

